RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Studying Cancer as an Adverse Outcome from Nononcological Therapies
Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract
Midkiff, K., Harris, D., Gilsenan, A., & Andrews, E. (2015). Studying Cancer as an Adverse Outcome from Nononcological Therapies: Review of the Food and Drug Administration's Postmarketing Commitment Database (Meeting Abstract. Pharmacoepidemiology and Drug Safety, 24(S1), 448-449. https://doi.org/10.1002/pds.3838